Skip to main content

Peptide Modification Knowledge Center

Services & Products


Get published in Nature

LifeTein Referral Rewards Program

Peptide Modification Knowledge Center

Almost every custom peptide we make carries at least one modification. The question is rarely whether to modify a sequence, but which change to make, where to put it, and what it will cost you elsewhere in the molecule. An unmodified peptide is usually cleared from circulation within minutes, and chemical modification is the established route to a usable pharmacokinetic profile — which is why half-life extension has its own substantial review literature.1,2

This index is organised by what you are trying to achieve, not by chemistry class. Pick the goal, follow the link, and the page behind it goes into the chemistry, the design decisions and the published work in detail. Every modification named here is one we make routinely.

Diagram of a peptide chain showing the three attachment regions: the N-terminus, amino acid side chains, and the C-terminus, with the modification types typically installed at each.
A peptide offers three regions for chemical modification, and the choice is usually dictated by where the sequence can tolerate a change. The N-terminus and C-terminus are single, unambiguous sites and are the default for capping groups, dyes, biotin and fatty acids. Side chains — principally lysine, cysteine, aspartate and glutamate — allow attachment in the middle of a sequence, at the cost of needing orthogonal protection during synthesis so that only the intended residue reacts.

Locking in a shape

Constraining a flexible sequence into the conformation that actually binds.

Capturing, pulling down and immobilising

Affinity handles, and the chemistry that attaches a peptide to a surface or a partner.

Raising an antibody against a peptide

Presenting a short sequence so the immune system treats it as an antigen.

Reproducing a post-translational modification

Synthetic peptides carrying the modification at a defined, homogeneous position.

Getting the peptide into cells

Cell-penetrating sequences, lipid carriers and the conjugates that use them.

Quantifying by mass spectrometry

Labelled standards, and reading a modified peptide's spectrum correctly.

Reference tables and handling

What to look up once the modified peptide is on the bench.

Not sure which modification you need? Send us the sequence and what you want the peptide to do in the experiment. Our chemists will tell you which modifications are compatible with that sequence, which are not, and what each would change. We send a quote within 24 hours.

Request a Quote

References

  1. van Witteloostuijn SB, Pedersen SL, Jensen KJ. Half-life extension of biopharmaceuticals using chemical methods: alternatives to PEGylation. ChemMedChem. 2016;11(22):2474–2495.
  2. Menacho-Melgar R, Decker JS, Hennigan JN, Lynch MD. A review of lipidation in the development of advanced protein and peptide therapeutics. J Control Release. 2019;295:1–12. doi:10.1016/j.jconrel.2018.12.032

All LifeTein products are supplied for laboratory research use only. They are not for human or veterinary use, and not for diagnostic or therapeutic use.